title: Nosocomial cluster of Candida lipolytica fungemia in pediatric patients.
abstract: Candida lipolytica has rarely been reported as a human pathogen. An apparent outbreak of Candida lipolytica fungemia (n = 5 cases) occurred in a pediatric ward over a 9-week period. The five patients infected were hospitalized in three adjacent rooms and cared for by the same healthcare workers. The index patient had central venous catheter-related fungemia, whereas the second patient, who was in the adjacent single room, had transient fungemia. Three additional cases of fungemia occurred in patients with hematological disorders who shared the same room; all three patients had central venous catheters and had been receiving oral fluconazole prophylaxis (50 mg/day for more than 3 weeks) at the time of infection. In vitro susceptibility testing of the strains showed that the MIC of fluconazole for all the isolates was 32 microg/ml. Random amplified polymorphic DNA analysis provided evidence of the clonal origin of the isolates, but the source of the outbreak was not identified. All four patients with persistent fungemia were successfully treated via catheter removal or empiric amphotericin B treatment. This outbreak shows the potential for the nosocomial epidemic transmission of Candida lipolytica.
authors.affiliation: Department of Internal Medicine, Chonnam University Medical School, Kwangju, Korea. shinjh@chonnam.chonnam.ac.kr
authors.forename: J H
authors.initials: JH
authors.lastname: Shin
authors.forename: H
authors.initials: H
authors.lastname: Kook
authors.forename: D H
authors.initials: DH
authors.lastname: Shin
authors.forename: T J
authors.initials: TJ
authors.lastname: Hwang
authors.forename: M
authors.initials: M
authors.lastname: Kim
authors.forename: S P
authors.initials: SP
authors.lastname: Suh
authors.forename: D W
authors.initials: DW
authors.lastname: Ryang
mesh_terms: D000293:Adolescent; D000935:Antifungal Agents / Q000494:pharmacology; D002175:Candida / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D002177:Candidiasis / Q000453:epidemiology* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D004196:Disease Outbreaks; D005260:Female; D016469:Fungemia / Q000453:epidemiology* / Q000382:microbiology; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D010372:Pediatrics; D019105:Random Amplified Polymorphic DNA Technique
chemical_list: D000935:Antifungal Agents